Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Performance of the Ductus Venosus Doppler at 16 Weeks Allow to Increase the Screening of the Twin-twin Transfusion Syndrome and to Reduce the Neonatal Mortality?

NCT03579069 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03579069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03579069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Performance of the Ductus Venosus Doppler at 16 Weeks Allow to Increase the Screening of the Twin-twin Transfusion Syndrome and to Reduce the Neonatal Mortality?
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
June 20, 2018
Completion date
December 31, 2018
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy followed, twin pregnancy, monochorionic